These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37752707)

  • 1. COVID-19, Obesity, and GRP78: Unraveling the Pathological Link.
    Shin J; Shimomura I
    J Obes Metab Syndr; 2023 Sep; 32(3):183-196. PubMed ID: 37752707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors.
    Shin J; Toyoda S; Fukuhara A; Shimomura I
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability of The Male Reproductive System to SARS-CoV-2 Invasion: Potential Role for The Endoplasmic Reticulum Chaperone Grp78/HSPA5/BiP.
    Sadeghi N; Tavalaee M; Shahverdi A; Sengupta P; Leisegang K; Saleh R; Agarwal A; Nasr Esfahani MH
    Cell J; 2022 Aug; 24(8):427-433. PubMed ID: 36093801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
    Chen P; Wu M; He Y; Jiang B; He ML
    Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.
    Maleksabet H; Rezaee E; Tabatabai SA
    Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.
    Allam L; Ghrifi F; Mohammed H; El Hafidi N; El Jaoudi R; El Harti J; Lmimouni B; Belyamani L; Ibrahimi A
    Bioinform Biol Insights; 2020; 14():1177932220965505. PubMed ID: 33149560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells.
    Chu H; Chan CM; Zhang X; Wang Y; Yuan S; Zhou J; Au-Yeung RK; Sze KH; Yang D; Shuai H; Hou Y; Li C; Zhao X; Poon VK; Leung SP; Yeung ML; Yan J; Lu G; Jin DY; Gao GF; Chan JF; Yuen KY
    J Biol Chem; 2018 Jul; 293(30):11709-11726. PubMed ID: 29887526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients.
    Shahriari-Felordi M; Alikhani HK; Hashemian SR; Hassan M; Vosough M
    Mol Biol Rep; 2022 Feb; 49(2):1545-1549. PubMed ID: 35028855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
    Wu T; Zhang H; Hu E; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.